Clinical Trial

Prospective, Long-term Evaluation of the SAPIEN 3 Ultra RESILIA Valve

Study acronym: RESOUND-EU
Recruiting
View on ClinicalTrials.gov →
Summary
Evaluation of clinical outcomes and valve performance of the SAPIEN 3 Ultra Resilia (S3UR) valve over 10 years.
Protocol Amendment History 1 change
critical Recruitment opened 2026-07-31
Trial Details
NCT Number NCT06953206
Lead Sponsor Institut für Pharmakologie und Präventive Medizin
Conditions Transcatheter Aortic Valve Replacement (TAVR), Aortic-Stenosis, Aortic Insufficiency, Degenerative Valve Disease
Enrollment 500 participants
Start Date 2025-09-15
Primary Completion 2037-05-30 (estimated)
Study Completion 2037-09-30 (estimated)
Updated on ClinicalTrials.gov 2026-07-30